Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range
Dec 23, 2011 shields james Officer Acquisition (Non Open Market) 86,500 14.77
Dec 23, 2011 shields james Officer Disposition (Non Open Market) 36,719 14.77
Dec 23, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 520,000 14.77
Dec 23, 2011 shrotriya rajesh c md Officer Disposition (Non Open Market) 189,540 14.77
Nov 29, 2011 shields james Officer Acquisition (Non Open Market) 10,000 n/a
Nov 29, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 600,000 n/a
May 13, 2011 maida anthony e iii Director Sell 3,000 7.59
May 13, 2011 maida anthony e iii Director Option Execute 3,000 2.55
Jan 20, 2011 scott brett l Officer Buy 4,000 6.05
Jan 3, 2011 kumaria shyam k Officer Acquisition (Non Open Market) 20,000 n/a
Jan 3, 2011 shields james Officer Acquisition (Non Open Market) 20,000 n/a
Jan 3, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 250,000 n/a
Jan 3, 2011 tidmarsh george f Officer Acquisition (Non Open Market) 20,000 n/a
Dec 23, 2010 shields james Officer Statement of Ownership 0 n/a
Nov 16, 2010 maida anthony e iii Director Sell 5,000 4.46
Nov 16, 2010 maida anthony e iii Director Option Execute 5,000 2.55
Aug 13, 2010 tidmarsh george f Officer Buy 5,000 4.03
Jul 15, 2010 tidmarsh george f Officer Acquisition (Non Open Market) 15,000 n/a
Jul 6, 2010 mehta dilip j md phd Director Buy 10,000 3.74
Jul 1, 2010 lenaz luigi md Director Statement of Ownership 0 n/a
Showing 201-220 of 267 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
9.45
Change:
- 0.36
Day High:
9.90
Day Low:
9.03
Volume:
1,947,261
4:00 PM ET on Sep 22, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR